About Biosense
Biosense is a Healthcare company based in Mumbai (India) founded in 2008 by Darshan Hammanna Nayak, and was acquired by Tulip Diagnostics in November 2019. Diagnostic devices for multiple diseases are developed and provided. It operates on a HealthTech and Direct-to-Consumer (D2C) model. Biosense has raised $4.77 million across 17 funding rounds from investors including Prudent, Kae Capital and HHS. The company has 64 employees. Biosense was last valued at $5.65 million in October 2017. Its Indian entity Biosense Technologies Private Limited reported revenue of ₹16.89 Cr. Biosense offers products and services including SYNC Glucometer, Uchek, and ToucHb. Its focus areas include Medical Devices and Diagnostic Equipment. Its competitors include EzeRx and KRIYA; 2 of its 2 listed competitors have raised funding.
Company details
Biosense is focused on creating technologically advanced, user-friendly medical devices for screening and managing health conditions. The company targets critical areas such as diabetes, anaemia, and malnutrition through products like SYNC Glucometer, Uchek, and ToucHb. Solutions are designed to reduce the burden on primary healthcare services while empowering users with real-time health management tools. Operations are centered in the healthcare sector, emphasizing diagnostic equipment for widespread conditions in India and beyond.
- Headquarters Mumbai, India
- Employees 64
- Founders Darshan Hammanna Nayak
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website biosense.in
- Social LinkedIn X Facebook Instagram
- Acquired by Tulip Diagnostics (Nov 2019)
- Legal Name Biosense Technologies Private Limited
- Date of Incorporation 05 Dec, 2008
- Jurisdiction Thane, Maharashtra, India
- Annual Revenue₹16.89 Cr
FY 2025 · +4% YoY
- Net Profit₹19.3 Lakh
FY 2025 · 1% margin
- EBITDA₹1.48 Cr
FY 2025 · 9% margin
- Total Equity Funding$4.77M (USD)
in 17 rounds
- Latest Funding Round$1M (USD), Seed
Apr 2018
- InvestorsPrudent
& 25 more
- Employee Count64
- Acquired byTulip Diagnostics
(Nov 2019)
Associated legal entities of Biosense
Biosense is associated with 2 registered companies on The Company Check; the primary company is Biosense Technologies Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biosense Technologies Private Limited CIN U85100MH2008PTC188729 | Active | 05 Dec 2008 | Bhiwandi, Maharashtra | ₹16.9 Cr | 64 | 3 | View details |
| Tulip Diagnostics Private Limited CIN U85195GA1988PTC005717 | Active | 14 Dec 1988 | Tiswadi, Goa | ₹553 Cr | 1,416 | 3 | View details |
Products & Services of Biosense
Biosense offers a comprehensive portfolio of products and services, including SYNC Glucometer, Uchek, and ToucHb.
A compact glucometer is designed for personal use.
A smartphone-based system is used for urine analysis.
A non-invasive device is used for anaemia screening.
Funding Insights of Biosense
Biosense has successfully raised a total of $4.77M across 17 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.77M
- Total Rounds 17
- Last Round Seed — $1M
- First Round $429,080
(Jan 2008)
- Investors Count 25
Latest 10 of 17 funding rounds of Biosense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2018 | $1M | Seed | – | Artha Venture Challenge | |
| Oct 2017 | $2.03M | Seed | $5.65M | Menterra Venture Advisors | |
| Aug 2016 | $535,334 | Seed | $5.63M | Insitor Partners | |
| Jul 2016 | $203,215 | Grant | – | – | |
| Jun 2016 | $298,179 | Seed | $••••• | Menterra Venture Advisors | – |
| Dec 2014 | $403,553 | Seed | $••••• | Insitor Partners | |
| Aug 2013 | $1.21M | Grant | – | – | |
| Jan 2013 | $500,000 | Seed | $••••• | GSF, Insitor Partners | |
| Sep 2011 | $199,691 | Grant | – | – | |
| Jun 2010 | $2M | Grant | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Oct 2017 | $5.65M | •••••••• |
| Aug 2016 | $5.63M | •••••••• |
| Jun 2016 | $••••• | •••••••• |
| Dec 2014 | $••••• | •••••••• |
| Jan 2013 | $••••• | •••••••• |
Full valuation and stage history of Biosense
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $5.65M (Oct 2017). 26 investors in total: 11 institutional and 15 angel.
Investors in Biosense
Biosense has secured backing from 26 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Prudent, Kae Capital and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments in social impact sectors such as agriculture, healthcare, and education in India. | 2015 | menterra.com | Bengaluru, India | |
Sector agnostic startup incubator | arthaventurechallenge.com | Zurich, Switzerland | ||
Provider of impact investment firm based in Singapore focused on investing in startups and early-stage social businesses | insitorpartners.com | Singapore, Singapore | ||
Early-stage consumer brand companies are invested in by Fireside Ventures. | firesideventures.com | Bengaluru, India | ||
Venture capital investments in Indian startups across various sectors. | 2017 | artha.vc | Mumbai, India | |
Bro138 is recognized as a trusted online slot platform in Indonesia. | gsfaccelerator.com | Delhi, India | ||
Early-stage investing in tech startups in India. | 2011 | kae-capital.com | Mumbai, India | |
Venture capital firm focused on early-stage investments | ntholdings.tcc.mode | Bengaluru, India | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Provider of financial products and investment services | 2000 | prudentcorporate.com | Ahmedabad, India |
Investor details for Biosense
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Biosense Technologies Private Limited (Biosense)
Biosense Technologies Private Limited is the primary company behind Biosense. The boards of the 2 registered companies of Biosense currently have 3 directors; the longest-serving is Alok Kumar, appointed in 2017. 20 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Alok Kumar DIN 05119699 | Director | 31 Jan 2017 | 9 yrs 8 mo | Tulip Diagnostics Private Limited, Biosense Technologies Private Limited |
| Deepak Gurushankar Tripathi DIN 02021472 | Director | 05 May 2017 | 9 yrs 5 mo | Tulip Diagnostics Private Limited, Biosense Technologies Private Limited |
| Narendra Makkar DIN 07940889 | Director | 19 Sep 2017 | 9 yrs 1 mo | Tulip Diagnostics Private Limited, Biosense Technologies Private Limited |
People of Biosense
1 people are tracked at Biosense (1 in leadership); the tracked headcount is 64.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership |
Complete people profiles for Biosense
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Biosense
Figures of Biosense Technologies Private Limited, the primary company behind Biosense, for FY 2025. Revenue was ₹16.89 Cr (+4% year on year). Net profit was ₹19.3 Lakh (1% margin). EBITDA was ₹1.48 Cr (9% margin). Revenue has grown at a compounded annual rate of -35% over three years and -2% over five years.
- ₹16.89 CrRevenue · FY 2025 · +4% YoY
- ₹19.3 LakhNet profit · 1% margin
- ₹1.48 CrEBITDA · 9% margin
- ₹6.6 LakhPaid-up capital
- 64Employees (provident fund records)
- -35%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Biosense Technologies Private Limited are on its company page.
Detailed financial statements for Biosense
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Biosense
5 dated milestones of Biosense across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Biosense is founded.
- Funding First funding round of $429K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $1.0M.
- Exit Acquired by Tulip Diagnostics.
Competitors of Biosense
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ezerx.in | 2018 | Bhubaneswar, India | $4.41M | Non-invasive IoT diagnostic devices are manufactured for accessible health screening. | ||
| kriyamed.com | 2010 | Chennai, India | $4.5M | 138 | Developer of health care products for diagnosis and treatment |
Detailed competitors of Biosense
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biosense
The website of Biosense (biosense.in) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 121.1% vs previous month
Websites whose visitors overlap most with Biosense. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| tytocare.com | 100% | 24.1K | #1,009,254 | View details | |
| biosensewebster.com | 96% | 1.9K | #8,363,106 | View details | |
medgadget.com | medgadget.com | 89% | – | ||
| cdc.gov | 89% | 16.4M | #4,309 | View details | |
| biocon.com | 54% | 82.3K | #297,196 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biosense
Complete news archive for Biosense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biosense
Biosense was founded in 2008.
Biosense is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Biosense is a funded company, having raised a total of $4.77M across 17 funding rounds to date. The company's 1st funding round was a Grant of $2M, raised on Jan 2008.
Biosense has 64 employees.
The primary company behind Biosense, Biosense Technologies Private Limited, reported revenue of ₹16.89 Cr for FY 2025, up 4% year on year.
Biosense is focused on creating technologically advanced, user-friendly medical devices for screening and managing health conditions. The company targets critical areas such as diabetes, anaemia, and malnutrition through products like SYNC Glucometer, Uchek, and ToucHb. Solutions are designed to reduce the burden on primary healthcare services while empowering users with real-time health management tools. Operations are centered in the healthcare sector, emphasizing diagnostic equipment for widespread conditions in India and beyond.
Biosense offers SYNC Glucometer, Uchek, and ToucHb.
Biosense has 26 investors. Key investors include Prudent, Kae Capital, HHS, Artha Venture Fund, and Tulip Diagnostics.
The valuation of Biosense is $5.65M as of Oct 2017.
Biosense is associated with 2 legal entities: Biosense Technologies Private Limited, Tulip Diagnostics Private Limited.
Yes. Biosense was acquired by Tulip Diagnostics in November 2019.